Cravatex Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
For the full year, sales was INR 2,026.32 million compared to INR 5,036.59 million a year ago. Revenue was INR 2,187.32 million compared to INR 5,161.28 million a year ago. Net income was INR 48.28 million compared to INR 589.33 million a year ago. Basic earnings per share from continuing operations was INR 18.68 compared to INR 228.05 a year ago. Diluted earnings per share from continuing operations was INR 18.68 compared to INR 228.05 a year ago.